ZA91918B - 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation - Google Patents

17beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation

Info

Publication number
ZA91918B
ZA91918B ZA91918A ZA91918A ZA91918B ZA 91918 B ZA91918 B ZA 91918B ZA 91918 A ZA91918 A ZA 91918A ZA 91918 A ZA91918 A ZA 91918A ZA 91918 B ZA91918 B ZA 91918B
Authority
ZA
South Africa
Prior art keywords
5alpha
17beta
androstan
aza
derivatives
Prior art date
Application number
ZA91918A
Other languages
English (en)
Inventor
Achille Panzeri
Panzeri Achille
Enrico Di Salle
Di Salle Enrico
Marcella Nesi
Nesi Marcella
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA91918B publication Critical patent/ZA91918B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA91918A 1990-02-09 1991-02-07 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation ZA91918B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909002922A GB9002922D0 (en) 1990-02-09 1990-02-09 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
ZA91918B true ZA91918B (en) 1991-11-27

Family

ID=10670693

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91918A ZA91918B (en) 1990-02-09 1991-02-07 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation

Country Status (26)

Country Link
US (1) US5155107A (pt)
EP (1) EP0468012B1 (pt)
JP (1) JPH04505462A (pt)
KR (1) KR920701234A (pt)
CN (1) CN1054771A (pt)
AT (1) ATE128143T1 (pt)
AU (1) AU642215B2 (pt)
CA (1) CA2049318A1 (pt)
CZ (1) CZ279484B6 (pt)
DE (1) DE69113155T2 (pt)
DK (1) DK0468012T3 (pt)
ES (1) ES2080297T3 (pt)
FI (1) FI914723A0 (pt)
GB (1) GB9002922D0 (pt)
GR (1) GR3017996T3 (pt)
HR (1) HRP921221A2 (pt)
HU (1) HUT59158A (pt)
IE (1) IE910408A1 (pt)
IL (1) IL97025A (pt)
MY (1) MY105402A (pt)
NO (1) NO913923L (pt)
NZ (1) NZ237023A (pt)
PT (1) PT96699A (pt)
RU (1) RU2088589C1 (pt)
WO (1) WO1991012261A1 (pt)
ZA (1) ZA91918B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9115676D0 (en) * 1991-07-19 1991-09-04 Erba Carlo Spa Process for the preparation of 17 beta substituted-4-aza-5 alpha-androstan-3-one derivatives
CA2084799C (en) 1991-12-17 2003-01-28 Glenn J. Gormley Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
US5543406A (en) * 1991-12-20 1996-08-06 Glaxo Wellcome, Inc. Inhibitors of 5-α-testosterone reductase
US5237064A (en) * 1992-05-20 1993-08-17 Merck & Co., Inc. Process for producing 7β-substituted-aza-5αandrostan-3-ones
AU675225B2 (en) * 1992-05-20 1997-01-30 Merck & Co., Inc. 17-amino substituted 4-azasteroid 5alpha-reductase inhibitors
ATE195129T1 (de) * 1992-05-20 2000-08-15 Merck & Co Inc 4-azasteroide als 5-alpha-reduktase
DE69329856D1 (de) * 1992-05-20 2001-02-15 Merck & Co Inc Ester derivate von 4-aza-steroiden
RU94046044A (ru) * 1992-05-20 1996-10-10 Мерк Энд Ко. Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения
EP0641204B1 (en) * 1992-05-20 2000-08-16 Merck & Co. Inc. 17-ethers and thioethers of 4-aza-steroids
WO1993023053A1 (en) * 1992-05-21 1993-11-25 Endorecherche Inc. INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
GB9216329D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa 17beta-substituted 4-aza-5alpha-androstan-3-one derivatives
GB9216280D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Steroids with a fluorinated acylureidic type side chain
US5302589A (en) * 1992-08-07 1994-04-12 Glaxo, Inc. Heterocyclic inhibitors of 5-α-testosterone reductase
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5359071A (en) * 1993-03-12 1994-10-25 Merck & Co., Inc. 15-substituted 4-azasteroids
AU6413594A (en) * 1993-03-24 1994-10-11 Merck & Co., Inc. Substituted 3-phenanthridinone derivatives as 5alpha-reductase inhibitors
JP3325026B2 (ja) * 1993-06-28 2002-09-17 メルク エンド カンパニー インコーポレーテッド ４−アザ−プレグナン５α−レダクターゼアイソザイム１阻害剤
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
CN1072679C (zh) * 1995-07-30 2001-10-10 重庆医科大学 一种氮杂甾体化合物、制备及其用途
GB9518858D0 (en) * 1995-09-14 1995-11-15 Pharmacia Spa Phenylsubstituted 4-azasteroid fluoroderivatives
JPH11513380A (ja) * 1995-09-27 1999-11-16 メルク エンド カンパニー インコーポレーテッド ５−αレダクターゼ阻害剤によるアンドロゲン性脱毛症の予防方法
GB9727522D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Process for preparing carboxamido-4-azasteroids
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
US7605152B2 (en) * 2002-01-15 2009-10-20 Merck & Co., Inc. 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
KR100503193B1 (ko) * 2002-08-19 2005-07-25 한미약품 주식회사 3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법
WO2005027901A1 (en) * 2003-09-25 2005-03-31 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2005092341A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Combination therapy for lower urinary tract symptoms
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法
WO2023070071A2 (en) * 2021-10-21 2023-04-27 The Board Of Trustees Of The University Of Illinois Small molecule activators of the immune system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA970692A (en) * 1971-11-08 1975-07-08 Walter Voigt METHODS OF INHIBITING THE ACTIVITY OF TESTOSTERONE 5.alpha.-REDUCTASE
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4220778A (en) * 1978-10-30 1980-09-02 G. D. Searle & Co. 8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates

Also Published As

Publication number Publication date
GB9002922D0 (en) 1990-04-04
AU642215B2 (en) 1993-10-14
NZ237023A (en) 1993-01-27
FI914723A0 (fi) 1991-10-07
EP0468012A1 (en) 1992-01-29
NO913923L (no) 1991-12-06
IL97025A (en) 1995-05-26
IE910408A1 (en) 1991-08-14
HUT59158A (en) 1992-04-28
NO913923D0 (no) 1991-10-07
CS9100274A2 (en) 1991-12-17
PT96699A (pt) 1991-10-31
MY105402A (en) 1994-09-30
AU7230791A (en) 1991-09-03
US5155107A (en) 1992-10-13
DE69113155D1 (de) 1995-10-26
JPH04505462A (ja) 1992-09-24
ATE128143T1 (de) 1995-10-15
CZ279484B6 (cs) 1995-05-17
KR920701234A (ko) 1992-08-11
GR3017996T3 (en) 1996-02-29
EP0468012B1 (en) 1995-09-20
ES2080297T3 (es) 1996-02-01
IL97025A0 (en) 1992-03-29
DK0468012T3 (da) 1995-11-06
CA2049318A1 (en) 1991-08-10
HRP921221A2 (en) 1995-12-31
WO1991012261A1 (en) 1991-08-22
RU2088589C1 (en) 1997-08-27
CN1054771A (zh) 1991-09-25
DE69113155T2 (de) 1996-02-29
HU913193D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
ZA91918B (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation
KR0179054B1 (en) Heterocyclic-cyclic amine derivatives
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
GB9024730D0 (en) Diazine derivatives
HU910930D0 (en) Process for the production of 2,8-dioxa-bicyclo/3.2.1/octane derivatives and medical preparations containing them
EG20048A (en) Process for preparing of 2-(4- hydroxypiperidino)-1-alkanol derivatives as antischemic agents
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PL306402A1 (en) Thiazole derivatives, method of obtaining them and pharmaceutical preparations containing such derivatives
MX9702919A (es) Derivados azo del acido 5-aminosalicilico para el tratameitno de la enfermedad inflamatoria intestinal.
HUT42770A (en) Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same
TW252979B (pt)
NZ220967A (en) 4-nitrogen substituted isoquinolin-3-ol derivatives and pharmaceutical compositions
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
MY106825A (en) Chemical intermediates
HU905030D0 (en) Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.